Patents by Inventor William E. Fieles

William E. Fieles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prognostic method
    Patent number: 11353458
    Abstract: Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that binds BCMA. Also provided are kits for measuring BCMA expression in a sample.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: June 7, 2022
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Danton Bounds, Jenny L. Craigen, William E. Fieles, Fiona M. Germaschewski, Gaelle Herledan, Lydia Lee, Patrick A. Mayes, Lee McCahon, Katherine (Nee Sully) Nevin, Jennifer Paterson, Manuel Rodriguez-Justo, Laura M. Seestaller-Wehr, James Tunstead, Kwee L. Yong
  • PROGNOSTIC METHOD
    Publication number: 20180306791
    Abstract: Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that binds BCMA. Also provided are kits for measuring BCMA expression in a sample.
    Type: Application
    Filed: October 28, 2016
    Publication date: October 25, 2018
    Inventors: Danton BOUNDS, Jenny L. CRAIGEN, William E. FIELES, Fiona M. GERMASCHEWSKI, Gaelle HERLEDAN, Lydia LEE, Patrick A. MAYES, Lee MCCAHON, Katherine (NEE SULLY) NEVIN, Jennifer PATERSON, Manuel RODRIGUEZ-JUSTO, Laura M. SEESTALLER-WEHR, James TUNSTEAD, Kwee L. YONG
  • TNFR-like protein with death domain
    Publication number: 20040147447
    Abstract: The present invention provides methods and compositions based on the identification of a Death Domain Expressing Tumor Necrosis Factor Receptor Family Homologue (DETH). The present invention further provides methods and compositions for modulating apoptosis.
    Type: Application
    Filed: March 1, 2004
    Publication date: July 29, 2004
    Applicant: AstraZeneca AB
    Inventors: Jian J. Lu, Bruce C. Gomes, William E. Fieles